# Acorai

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/acorai

- Industry: Medical Devices & Equipment
- Headquarters: Stockholm, Sweden
- Website: www.acorai.com
- Total disclosed funding: $4.5M
- Latest round: Seed (Jan 22, 2024)
- Investors on record: 3

## About

Based in Helsingborg, Sweden, and founded in 2019 by CEO Filip Peters, CTO Jakob Gelberg, and COO Kasper Bourdette, Acorai AB, a.k.a. Acorai operates as a medical devices and equipment company that focuses on developing heart failure management devices through non-invasive intracardiac pressure monitoring (ICPM) to help reduce hospitalizations and readmissions. In January 2024, Acorai AB raised USD 4 million in seed funding led by Solardis Health Ventures, with participation from KHP Ventures and Carma Fund Management.

The company’s product line includes the Acorai Heart Monitor, a heart failure management device that allows healthcare professionals to monitor intracardiac pressures non-invasively through a machine learning analysis of pressure dynamics in acoustics, vibratory, and waveform data related to pulmonary artery pressure (PAP), right atrial pressure (RAP), and pulmonary capillary wedge pressure (PCWP). The device leverages technologies such as sensor systems to enable cardiac insights, machine learning, and an intuitive interface to integrate into daily practice.

Acorai plans to use its proceeds from January 2024 funding to accelerate the creation and introduction of its heart monitor equipment.

## Funding rounds

- Seed, Jan 22, 2024, $4.5M — CARMA FUND Management, Meridian Health Ventures, Solardis Health Ventures

## Investors

- CARMA FUND Management (https://capitalatlas.ai/funds/carma-fund-management) — Seed
- Meridian Health Ventures (https://capitalatlas.ai/funds/meridian-health-ventures) — Seed
- Solardis Health Ventures (https://capitalatlas.ai/funds/solardis-health-ventures) — Seed